{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Arrhythmogenic Right Ventricular Cardiomyopathy",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_sotalol",
          "name": "Sotalol"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_amiodarone",
          "name": "Amiodarone"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_beta_blockers",
          "name": "Beta-blockers"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_dronedarone",
          "name": "Dronedarone"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_verapamil",
          "name": "Verapamil"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_disopyramide",
          "name": "Disopyramide"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_flecainide",
          "name": "Flecainide"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_procainamide",
          "name": "Procainamide"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_digoxin",
          "name": "Digoxin"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_lisinopril",
          "name": "Lisinopril"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_spironolactone",
          "name": "Spironolactone"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_hydrochlorothiazide",
          "name": "Hydrochlorothiazide"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_sotalol",
          "type": "Drug",
          "label": "Sotalol",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_amiodarone",
          "type": "Drug",
          "label": "Amiodarone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_beta_blockers",
          "type": "Drug",
          "label": "Beta-blockers",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dronedarone",
          "type": "Drug",
          "label": "Dronedarone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_verapamil",
          "type": "Drug",
          "label": "Verapamil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_disopyramide",
          "type": "Drug",
          "label": "Disopyramide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_flecainide",
          "type": "Drug",
          "label": "Flecainide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_procainamide",
          "type": "Drug",
          "label": "Procainamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_digoxin",
          "type": "Drug",
          "label": "Digoxin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lisinopril",
          "type": "Drug",
          "label": "Lisinopril",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_spironolactone",
          "type": "Drug",
          "label": "Spironolactone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_hydrochlorothiazide",
          "type": "Drug",
          "label": "Hydrochlorothiazide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Disease_ARVC",
          "type": "Disease",
          "label": "Arrhythmogenic Right Ventricular Cardiomyopathy",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Target_Beta_adrenergic_receptor",
          "type": "Target",
          "label": "Beta-adrenergic receptor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Pathway_Heart_regulation",
          "type": "Pathway",
          "label": "Heart rate and rhythm regulation",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Phenotype_Arrhythmia",
          "type": "Phenotype",
          "label": "Arrhythmia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Phenotype_SV_Tachycardia",
          "type": "Phenotype",
          "label": "Supraventricular Tachycardia",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Phenotype_Ventricular_Tachycardia",
          "type": "Phenotype",
          "label": "Ventricular Tachycardia",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_sotalol",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Sotalol 是β-拮抗剂，作用于β-肾上腺素受体"
        },
        {
          "source": "drug_amiodarone",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Amiodarone 通过调节心脏电生理特性影响心率"
        },
        {
          "source": "drug_beta_blockers",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "β-阻滞剂主要通过作用于β-肾上腺素受体来降低心搏频率"
        },
        {
          "source": "drug_dronedarone",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Dronedarone 通过多种机制影响心率，包含对β-受体的作用"
        },
        {
          "source": "drug_verapamil",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Verapamil 作为钙通道阻滞剂影响心脏节律"
        },
        {
          "source": "drug_disopyramide",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Disopyramide 可干预心脏传导与节律"
        },
        {
          "source": "drug_flecainide",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Flecainide 可降低心脏传导速度"
        },
        {
          "source": "drug_procainamide",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Procainamide 可用于治疗心律失常"
        },
        {
          "source": "drug_digoxin",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Digoxin 可增强心脏收缩力并影响心律"
        },
        {
          "source": "drug_lisinopril",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Lisinopril 可通过改善心脏功能间接影响心律"
        },
        {
          "source": "drug_spironolactone",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Spironolactone 作为利尿剂有助于心脏病患者"
        },
        {
          "source": "drug_hydrochlorothiazide",
          "target": "Target_Beta_adrenergic_receptor",
          "relation": "acts_on",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Hydrochlorothiazide 可用于减少心脏负担"
        },
        {
          "source": "Target_Beta_adrenergic_receptor",
          "target": "Pathway_Heart_regulation",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "β-肾上腺素受体在心脏调节通路中的核心作用"
        },
        {
          "source": "Pathway_Heart_regulation",
          "target": "Phenotype_Arrhythmia",
          "relation": "causes",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "心脏调节通路失调可导致心律失常"
        },
        {
          "source": "Pathway_Heart_regulation",
          "target": "Phenotype_SV_Tachycardia",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "心脏节律失调引起的超心速症"
        },
        {
          "source": "Pathway_Heart_regulation",
          "target": "Phenotype_Ventricular_Tachycardia",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "心脏电生理异常引起心室心动过速"
        },
        {
          "source": "drug_sotalol",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Sotalol 用于治疗心律失常，适用于患者"
        },
        {
          "source": "drug_amiodarone",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Amiodarone 能有效控制心律失常"
        },
        {
          "source": "drug_beta_blockers",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "β-阻滞剂广泛应用于心律失常的管理"
        },
        {
          "source": "drug_dronedarone",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Dronedarone 是心律靶向治疗的重要药物"
        },
        {
          "source": "drug_verapamil",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Verapamil 作为抗心律药物用途广泛"
        },
        {
          "source": "drug_disopyramide",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Disopyramide 可改善心率问题"
        },
        {
          "source": "drug_flecainide",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Flecainide 在某些心律失常中很有效"
        },
        {
          "source": "drug_procainamide",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Procainamide 在控制心律方面有效"
        },
        {
          "source": "drug_digoxin",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Digoxin 可能对控制心率有积极作用"
        },
        {
          "source": "drug_lisinopril",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Lisinopril 除心率外还改善心脏功能"
        },
        {
          "source": "drug_spironolactone",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "Spironolactone 可辅助性改善患者心脏功能"
        },
        {
          "source": "drug_hydrochlorothiazide",
          "target": "Disease_ARVC",
          "relation": "supports",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "Hydrochlorothiazide 可减轻心脏负担"
        },
        {
          "source": "Phenotype_Arrhythmia",
          "target": "Disease_ARVC",
          "relation": "associated_with",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "心律失常是心脏病的一种常见表现"
        },
        {
          "source": "Phenotype_SV_Tachycardia",
          "target": "Disease_ARVC",
          "relation": "associated_with",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "超心速症常见于 心脏病患者"
        },
        {
          "source": "Phenotype_Ventricular_Tachycardia",
          "target": "Disease_ARVC",
          "relation": "associated_with",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "心室心动过速与心脏病相关性高"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物通过作用于 β-受体和心脏节律通路来支持治疗心室心肌病",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "所有药物能够有效到达心脏组织并发挥作用"
    ],
    "uncertainties": [
      "某些药物的具体副作用仍需进一步评估"
    ],
    "next_focus_for_pi": [
      "确认是否需要进一步探索其他靶点和药物"
    ]
  }
}